These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 187879)

  • 1. Distribution pattern of radioactive labelled lipiodol-UF following intralymphatic application for therapy.
    Weissleder H; Pfannenstiel P; Peters PE
    Lymphology; 1976 Sep; 9(3):122-6. PubMed ID: 187879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of a digital whole body scanner to the dosimetry of intralymphatic 32P/131I Lipiodol.
    O'Connell EA; Steere HA; Trott NG
    Br J Radiol; 1976 Sep; 49(585):779-87. PubMed ID: 183852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose distribution in healthy and metastatic lymph nodes after endolymphatic radionuclide therapy. II. Rabbit experiments using 32phosphorus-tri-n-octyl-phosphate and 125 iodine-trioleate in lipidol UF].
    Magnus L
    Strahlentherapie; 1973 Jun; 145(6):631-43. PubMed ID: 4375316
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radiation dose to the lung following endolymphatic radionuclide therapy of melanoma of the lower limbs].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Jan; 161(1):23-9. PubMed ID: 2982221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphographically detectable long-term changes caused by endolymphatic radionuclide therapy (ELRT) in the infradiaphragmatic lymph system].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Apr; 161(4):239-43. PubMed ID: 2986321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dosimetry in rabbit lymph nodes following endolymphatic therapy using radionuclides].
    Magnus L
    Strahlentherapie; 1973 Nov; 146(5):566-75. PubMed ID: 4362314
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of endo-lymphatic therapy of the VX2 tumour in the rabbit. Investigations using the beta-ray source P 32-tri-N-octyl-phosphate and the gamma source I 125-trioleine (author's transl)].
    Magnus L
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Oct; 119(4):418-28. PubMed ID: 4359999
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dose distribution in healthy lymph nodes and in lymph nodes affected by metastases after endolymphatic therapy with radionuclides].
    Magnus L
    Strahlentherapie; 1973 May; 145(5):571-81. PubMed ID: 4761818
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reliability of the diagnostic results obtained with confined quantities of the contrast medium in endolymphatic radionuclide therapy (ELRT) of the inferior limbs (author's transl)].
    Müller RP; Schnepper E; Peters PE; Fladerer W
    Strahlentherapie; 1980 Aug; 156(8):538-41. PubMed ID: 7414647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indication establishment and dosimetry in endolymphatic therapy with I-131 lipiodol].
    Winkel K; Becker J; Jahns E; Scheurlen H; Herzfeld U
    Strahlentherapie; 1967 Aug; 133(4):481-98. PubMed ID: 4298455
    [No Abstract]   [Full Text] [Related]  

  • 11. Body distribution of intralymphatically injected radioactive colloid and oil.
    Erjavec M; Hacek S; Havlicek M; Klanjscek G
    Radiobiol Radiother (Berl); 1969; 10(4):571-8. PubMed ID: 4312058
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
    Makoski HB; Magnus L; Heissen E; Kolpatzik H; Drepper H
    Strahlentherapie; 1974 Jul; 148(1):1-15. PubMed ID: 4612879
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of pulmonary radioactivity in patients exposed to endolymphatic radiotherapy with lipiodol F-I 131].
    Bagliani G; Buraggi GL; De Vecchi A; Fava G
    Tumori; 1967; 53(3):225-35. PubMed ID: 4293146
    [No Abstract]   [Full Text] [Related]  

  • 14. Body distribution of Lipiodol 131-J following intralymphatic radiotherapy.
    Fava G; Roncoroni L
    Nucl Med (Stuttg); 1965 Dec; 5(1):1-11. PubMed ID: 4287956
    [No Abstract]   [Full Text] [Related]  

  • 15. [Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1].
    Kokoschka E
    Med Welt; 1974 Jun; 25(23):1054-5. PubMed ID: 4369551
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the distribution of lipiodol F 131 I introduced into the lymphatic vessels of the dog].
    Fava G; Bertoli MA; De Vecchi A; Giavelli S; Invernizzi A; Sichirollo AE
    Ateneo Parmense 1; 1971; 41(2):11-21. PubMed ID: 4342164
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vitality evaluation of malignant melanoma metastases following endolymphatic radionuclide therapy using the Falck-Hillarp method].
    Paul E; Illig L; Möller W
    Hautarzt; 1975 Jun; 26(6):317-20. PubMed ID: 1165195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kinetic studies following intralymphatic administration of radioactive substances. Its significance for the diagnosis and therapy of malignant tumors].
    Heinzel F; Rösler H; Rüttimann A; Wirth W
    Radiologe; 1968 May; 8(5):154-8. PubMed ID: 4302469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radionuclide treatment of lymph node metastases in malignant melanoma].
    Weissleder H; Pfannenstiel P
    Hautarzt; 1973 Jan; 24(1):21-4. PubMed ID: 4348909
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic intralymphatic isotope therapy.
    Mott TJ
    Proc R Soc Med; 1973 Dec; 66(12):1238-9. PubMed ID: 4777059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.